Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB314685

Integrin alpha 2/CD49b Antibody (HAS3), PE/Cy7, Novus Biologicals™
SDP

Catalog No. NB314685 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.5 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB314685 0.5 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB314685 Supplier Novus Biologicals Supplier No. FAB1233PECY7
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

Integrin alpha 2/CD49b Monoclonal antibody specifically detects Integrin alpha 2/CD49b in Human samples. It is validated for Flow Cytometry

Specifications

Antigen Integrin alpha 2/CD49b
Applications Flow Cytometry
Classification Monoclonal
Clone HAS3
Conjugate PE-Cyanine7
Dilution Flow Cytometry
Formulation PBS
Gene Alias alpha-2 subunit, CD49b antigen, integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor), VLA 2
Host Species Mouse
Immunogen Human keratinocytes
Purification Method Protein A or G purified from hybridoma culture supernatant
Quantity 0.5 mL
Regulatory Status RUO
Research Discipline Cellular Markers, Innate Immunity, Signal Transduction
Primary or Secondary Primary
Gene ID (Entrez) 3673
Target Species Human
Content And Storage Store at 4C in the dark. Do not freeze.
Form Purified
Isotype IgG2a
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.